| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |